Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-21
2011-06-21
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S448000, C549S071000, C544S146000
Reexamination Certificate
active
07964595
ABSTRACT:
Disclosed herein is a compound according to one of the formulaswherein R isAdditionally, pharmaceutically acceptable salt thereof, and methods of treating disease, medicaments, and compositions related thereto, are further elaborated herein.
REFERENCES:
patent: 6586463 (2003-07-01), deLong et al.
patent: 2005/0209337 (2005-09-01), Gutman
patent: WO 97/30710 (1997-08-01), None
patent: WO 00/51977 (2000-02-01), None
patent: WO 02 096868 (2002-12-01), None
patent: WO 2006/022966 (2006-03-01), None
Carey, Francis A.: Organic Chemistry, New York: McGraw-Hill Book Company 1987, p. 63.
Smith and March, March's Advanced Organic Chemistry, 5thEd., New York: Wiley-Interscience, 2001, pp. 1195-1196.
U.S. Appl. No. 60/805,285, filed Jul. 20, 2006, Old.
Burk Robert M.
Donde Yariv
Johnson Brent A.
Old David W..
Allergan Inc.
Chu Yong
Ene Doina G.
Forrestal Kevin J.
Rodriguez-Garcia Valerie
LandOfFree
Thiophenyl prostaglandin derivatives for treating glaucoma... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiophenyl prostaglandin derivatives for treating glaucoma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophenyl prostaglandin derivatives for treating glaucoma... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2667730